1 , but is itself phylogenetically limited to "
post-genome-
duplicated" budding yeasts.
2 In Saccharomyces cerevisiae, the
post-genome-
duplication Dig1/Dig2 proteins regulate MAP
3 In the
post genome era it will soon be possible to associate a
4 ral tagging for cancer gene discovery in the
post-genome era and indicate a largely unrecognized comp
5 Major challenges for biology in the
post-genome era are to map the molecular polymorphisms r
6 A significant goal in the
post-genome era is to relate the annotated genome sequen
7 Studying gene function in the
post-genome era requires methods to localize and inactiv
8 The
post-genome era requires novel strategies that address g
9 A major challenge in the
post-genome era will be determination of the functions o
10 es of investigation that will follow in the '
post-genome era'.
11 In the
post-genome era, attention has focused on the functions
12 As yeast research enters the
post-genome era, the development of existing deletion st
13 me Project has signaled the beginning of the
post-genome era, with a corresponding shift in focus fro
14 ed importance of genetic linkage maps in the
post-genome era.
15 s represents the next major challenge in the
post-genome era.
16 become a burgeoning area of research in the
post-genome era.
17 the patenting of genes has extended into the
post-genome era.
18 ral tagging for cancer gene discovery in the
post-genome era.
19 ceptualize problems and ask questions in the
post-genome era.
20 unction prediction is a key challenge in the
post-genome era.
21 of a wide range of microbial systems in the
post-genome era.
22 s a potent cancer gene discovery tool in the
post-genome-
sequence era.
23 In this exciting
post-genome sequencing era, many new epigenetic targets
24 ost interesting and challenging tasks in the
post-genome sequencing era.
25 As we are moving into the
post genome-
sequencing era, various high-throughput expe
26 lymorphisms (SNPs) are in high demand in the
post-genome-
sequencing era.
27 ssues, together with suggestions for optimal
post-genome strategies.
28 We performed both epidemiological and
post-genome wide association study (GWAS) analyses to in
29 In the
post genome-
wide association study (GWAS) era, omics tec
30 lity', which has emerged as an enigma in the
post-genome-
wide association studies (GWAS) era.
31 ults yielded by different methods applied in
post-genome-
wide association studies (post-GWAS) local c
32 complex disease susceptibility genes in the
post-genome-
wide association study (GWAS) era.
33 Post-genome-
wide association study analysis identified g
34 ns of COPD subtypes, protein biomarkers, and
post-genome-
wide association study analysis.
35 ation of Genome-Wide Association Studies for
post-genome-
wide association study annotations and Multi
36 One goal in the
post-genome-
wide association study era is characterizing
37 sease (IMD) has emerged as a priority in the
post-genome-
wide association study era.
38 Post-genome-
wide association study pipelines and molecul
39 (hap-ASM), have become a major focus in the
post-genome-
wide-association-study (GWAS) era.